Pacer Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.73M | Sell |
|
|||||
|
2025
Q2 | $3.55M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $512 | Buy |
|
|||||
|
2024
Q1 | $152 | Hold |
|
|||||
|
2023
Q4 | $144 | Sell |
|
|||||
|
2023
Q3 | $255 | Hold |
|
|||||
|
2023
Q2 | $551 | Buy |
|
|||||
|
2023
Q1 | $725 | Hold |
|
|||||
|
2022
Q4 | $827 | Sell |
|
|||||
|
2022
Q3 | $5.57M | Buy |
|
|||||
|
2022
Q2 | $3K | Hold |
|
|||||
|
2022
Q1 | $5K | Sell |
|
|||||
|
2021
Q4 | $6K | Sell |
|
|||||
|
2021
Q3 | $261K | Sell |
|
|||||
|
2021
Q2 | $429K | Buy |
|
|||||
|
2021
Q1 | $566K | Sell |
|
|||||
|
2020
Q4 | $607K | Sell |
|
|||||
|
2020
Q3 | $1.24M | Buy |
|
|||||
|
2020
Q2 | $4K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $686K | Buy |
|
|||||
|
2018
Q3 | $205K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $62K | Buy |
|
|||||
|
2017
Q4 | $31K | Buy |
|